Explore by goal

Body Composition

Areas of research involving lean mass, fat distribution, and body-composition measures.

Category

Evidence level

Regulatory / research status

Semaglutide

A GLP-1 receptor agonist medication approved for specific medical indications and extensively studied in clinical trials.

Glucose regulation researchAppetite signallingBody-composition research
Established clinical evidenceFDA-approved for a specific indication

Sermorelin

A growth hormone-releasing hormone analogue historically used in specific clinical diagnostic and treatment contexts.

Endocrine researchBody-composition researchAge-related hormonal change
Human evidence availableOther / status requires context

Tirzepatide

Premium

A dual receptor agonist medication approved for specific medical indications and studied in large clinical trials.

Glucose regulation researchBody-composition research
Established clinical evidenceFDA-approved for a specific indication

Ipamorelin

Premium

A growth hormone secretagogue peptide studied in research settings related to endocrine signalling.

Endocrine researchBody-composition research
Primarily preclinical researchResearch-stage

CJC-1295

Premium

A growth hormone-releasing hormone analogue studied in early research and often discussed alongside other secretagogues.

Endocrine researchBody-composition research
Early or emerging human evidenceInvestigational